- Home
- KOD vs OXSQ Comparison
KOD vs OXSQ Comparison
Compare KOD & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- OXSQ
- Stock Information
- Founded
- KOD 2009
- OXSQ 2003
- Country
- KOD United States
- OXSQ United States
- Employees
- KOD N/A
- OXSQ N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- OXSQ Blank Checks
- Sector
- KOD Health Care
- OXSQ Finance
- Exchange
- KOD Nasdaq
- OXSQ Nasdaq
- Market Cap
- KOD 188.9M
- OXSQ 164.9M
- IPO Year
- KOD 2018
- OXSQ N/A
- Fundamental
- Price
- KOD $3.67
- OXSQ $2.25
- Analyst Decision
- KOD Hold
- OXSQ
- Analyst Count
- KOD 3
- OXSQ 0
- Target Price
- KOD $9.00
- OXSQ N/A
- AVG Volume (30 Days)
- KOD 292.9K
- OXSQ 534.3K
- Earning Date
- KOD 08-13-2025
- OXSQ 08-12-2025
- Dividend Yield
- KOD N/A
- OXSQ 18.88%
- EPS Growth
- KOD N/A
- OXSQ N/A
- EPS
- KOD N/A
- OXSQ N/A
- Revenue
- KOD N/A
- OXSQ $42,166,831.00
- Revenue This Year
- KOD N/A
- OXSQ N/A
- Revenue Next Year
- KOD N/A
- OXSQ N/A
- P/E Ratio
- KOD N/A
- OXSQ N/A
- Revenue Growth
- KOD N/A
- OXSQ N/A
- 52 Week Low
- KOD $1.92
- OXSQ $2.14
- 52 Week High
- KOD $11.60
- OXSQ $3.10
- Technical
- Relative Strength Index (RSI)
- KOD 51.01
- OXSQ 35.49
- Support Level
- KOD $3.55
- OXSQ $2.14
- Resistance Level
- KOD $3.82
- OXSQ $2.33
- Average True Range (ATR)
- KOD 0.30
- OXSQ 0.03
- MACD
- KOD -0.02
- OXSQ -0.00
- Stochastic Oscillator
- KOD 35.00
- OXSQ 47.37
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.